A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer

NCT01234311 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1245

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: tasquinimod
DRUG: Placebo

Sponsor

Active Biotech AB